A new multi-national, multi-institutional study led by senior author Dr. Guinevere Lee, Assistant Professor of Virology in Medicine in the division of Infectious Diseases in the Weill Department of Medicine, found little natural resistance to a new HIV therapy called lenacapavir in a population of patients in Uganda.
The study, published Jan. 30 in the Journal of Antimicrobial Chemotherapy, adds to growing evidence that lenacapavir may be a powerful new tool in the global anti-...